dihydroisocombretastatin A4 derivatives (CNRS)

N/A

Report date: 2026/03/30 17:02:26

Base Information

Drug Namedihydroisocombretastatin A4 derivatives (CNRS)
Drug Alias Namecombretastatin A4 analogs (CNRS)CA4 analogs (CNRS)dihydroiso-CA4 derivatives (CNRS)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionTubulin modulators
TargetsTubulin
Therapy Area/IndicationsSolid tumours
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryFrance
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesCentre National De La Recherche Scientifique (Cnrs)
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesCNRS InnovationCentre National De La Recherche Scientifique (Cnrs)
Active IndicationsN/A
Inactive IndicationsSolid tumours

Other Information

ATC CodeN/A
Related LinksN/A